These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15853636)

  • 41. Eating and sleeping--their relationship to ghrelin and leptin.
    Steiger A
    Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1031-2. PubMed ID: 15475500
    [No Abstract]   [Full Text] [Related]  

  • 42. Developments in ghrelin biology and potential clinical relevance.
    Smith RG; Jiang H; Sun Y
    Trends Endocrinol Metab; 2005 Nov; 16(9):436-42. PubMed ID: 16213742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of thermal therapy in lifestyle-related diseases.
    Biro S; Masuda A; Kihara T; Tei C
    Exp Biol Med (Maywood); 2003 Nov; 228(10):1245-9. PubMed ID: 14610268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ghrelin plasma levels and appetite in peritoneal dialysis patients.
    Aguilera A; Cirugeda A; Amair R; Sansone G; Alegre L; Codoceo R; Bajo MA; del Peso G; Díez JJ; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2004; 20():194-9. PubMed ID: 15384825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach.
    Kojima M; Hosoda H; Kangawa K
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):517-30. PubMed ID: 15533773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.
    Nagaya N; Moriya J; Yasumura Y; Uematsu M; Ono F; Shimizu W; Ueno K; Kitakaze M; Miyatake K; Kangawa K
    Circulation; 2004 Dec; 110(24):3674-9. PubMed ID: 15569841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ghrelin Physiology and Pathophysiology: Focus on the Cardiovascular System].
    Gruzdeva OV; Borodkina DA; Belik EV; Akbasheva OE; Palicheva EI; Barbarash OL
    Kardiologiia; 2019 Apr; 59(3):60-67. PubMed ID: 30990143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormones and drinking behaviour: new findings on ghrelin, insulin, leptin and volume-regulating hormones. An ESBRA Symposium report.
    Addolorato G; Leggio L; Hillemacher T; Kraus T; Jerlhag E; Bleich S
    Drug Alcohol Rev; 2009 Mar; 28(2):160-5. PubMed ID: 19320701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.
    Inui A; Asakawa A; Bowers CY; Mantovani G; Laviano A; Meguid MM; Fujimiya M
    FASEB J; 2004 Mar; 18(3):439-56. PubMed ID: 15003990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight.
    Otukonyong EE; Dube MG; Torto R; Kalra PS; Kalra SP
    Peptides; 2005 Dec; 26(12):2559-66. PubMed ID: 15936848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits.
    Prior LJ; Davern PJ; Burke SL; Lim K; Armitage JA; Head GA
    Hypertension; 2014 Feb; 63(2):338-45. PubMed ID: 24191287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ghrelin: a hormone regulating food intake and energy homeostasis.
    Gil-Campos M; Aguilera CM; Cañete R; Gil A
    Br J Nutr; 2006 Aug; 96(2):201-26. PubMed ID: 16923214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease.
    Mak RH; Cheung W; Cone RD; Marks DL
    Pediatr Nephrol; 2005 Mar; 20(3):427-31. PubMed ID: 15662537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The YY3-36 peptide, a new therapeutic weapon against obesity?].
    Jégou S; Mounien L; Boutelet I; Vaudry H
    Med Sci (Paris); 2003 May; 19(5):537-9. PubMed ID: 12836385
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
    Lebrethon MC; Aganina A; Fournier M; Gérard A; Parent AS; Bourguignon JP
    J Neuroendocrinol; 2007 Mar; 19(3):181-8. PubMed ID: 17280591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central and peripheral activities of ghrelin, a ligand of the growth hormone secretagogue receptor.
    Bona G; Bellone S
    Panminerva Med; 2003 Sep; 45(3):197-201. PubMed ID: 14618118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy.
    Ueno N; Dube MG; Inui A; Kalra PS; Kalra SP
    Endocrinology; 2004 Sep; 145(9):4176-84. PubMed ID: 15155574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.